Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vienna Interventional Management of Stroke Study
2011-002775-42Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Modified Rankin Scale good outcome at 3 months. Started Nov 2012; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2011-002775-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002775-42.